Latest On-Demand Webinars & Online Events
Genomic tools for Psilocybe cubensis propagation
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.
Innovations in Disease Modeling 2022
This inaugural online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organ-on-a-chip and organoid models, as well as, how innovations are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.
Comprehensive Analysis of Next-Generation Biologics
New methods, techniques and efficient data analysis software in liquid chromatography-tandem mass spectrometry (LC-MS/MS) hold the key for accelerating the development of NGBs and increasing their availability.
Zooming in on SARS-CoV-2 Replication to Develop Antiviral Therapies
Antiviral drugs that slow SARS-CoV-2 replication in patient cells are critical for curbing the pandemic. For RNA viruses such as SARS-CoV-2, genome duplication hinges on RNA polymerase, making the enzyme an ideal therapeutic target for drug development.
Mapping Gene Expression Signatures in the Heart and Lungs of Patients with COVID-19
These technologies can help identify new strategies to enhance myocardial repair and regeneration through target validation and manipulation.
T Cells in COVID-19 – Translating Research Findings Into Clinical Options
Analysis of SARS-CoV-2-specific T cells is important in understanding their role during acute disease and in long-term protection. Find out about some of the tools used in T-cell research and the promise they show as a cell therapy for COVID-19.
Laboratory of the Future 2022
Advances in automation and digitization are remodeling how labs are built and run from the ground up. This free-to-attend event will provide researchers the opportunity to hear about the technologies helping to drive digital transformation and laboratory efficiencies.
Advanced Technology To Accelerate Development of Next-Generation Biotherapeutics
Biopharmaceutical companies are transitioning from the development of standard monoclonal antibody therapies to more intricate antibody structures and new genetic medicines. Not only are these molecules more complex, but scientists are also under tremendous pressure to understand molecular liabilities sooner and close the developability gap in a much shorter time frame.
Intestinal Organoids and Their Role in Tissue Engineering
This webinar will explore how we can isolate and expand patient-derived intestinal organoids in culture. By combining these organoids with scaffolds, we can generate functional intestinal mucosal grafts which demonstrate a proof-of-concept for subsequent clinical translation and future use in patients.
High-Throughput Proteomics During a Pandemic
Recent technical advances allow investigators to analyze clinical samples with robust high-throughput proteomic workflows, creating an opportunity to analyze large numbers of patient samples during the COVID-19 pandemic.